This interplay is recognized as a key driver of metaflammation, as ATMs actively contribute to systemic low-grade inflammation in obesity through the secretion of pro-inflammatory cytokines such as TNF-α, IL-6, and IL-1β, which are major instigators of the insulin resistance phenomenon [148,149]. This evidence concerns the gene IL6 and obesity disorder.